Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03152357 · ClinicalTrials.gov registry record
A Retrospective Study to Evaluate the ConforMIS iUni, iDuo & iTotal® KRS
A clinical trial of Osteoarthritis, Knee and Knee Osteoarthritis, sponsored by Restor3D.
- Completed
- Registry status
- 950
- Enrollment target
- 1
- Study location
NCT03152357: Completed study of Osteoarthritis, Knee and Knee Osteoarthritis, sponsored by Restor3D.
NCT03152357 is a study of Osteoarthritis, Knee and Knee Osteoarthritis that has completed, run by Restor3D. The registered enrollment target is 950 participants, above the 489-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (94% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03152357, a study of Osteoarthritis, Knee and Knee Osteoarthritis, has completed, sponsored by Restor3D.
- COMPLETED
- Registry status
- 950 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to evaluate implant survivorship, patient satisfaction, and patient-reported outcomes of subjects who have undergone surgery with any of the following ConforMIS knee implants: the iUni®, iDuo® or iTotal® Cruciate Retaining (CR) Knee Replacement Systems.
Primary Outcome
Survivorship of the implant--whether or not the patient has had a surgical revision prior to data collection.
Conditions Studied
Interventions
- DEVICE ConforMIS iUni, iDuo, or iTotal (CR)
Study Locations (1)
Florida
- Preferred Orthopedics of the Palm Beaches - Boynton Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 950 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2019-12-31 |
What the finished NCT03152357 record still lists
NCT03152357 is an observational study that tracks outcomes without assigning an intervention. The registered 950 participants enrollment target is mid-sized for trials with a published cap, above the 489-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (94% higher).
The record links to 2 conditions, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which ConforMIS iUni, iDuo, or iTotal (CR) is the first listed.
NCT03152357 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03152357 about?
NCT03152357 is a clinical study titled "A Retrospective Study to Evaluate the ConforMIS iUni, iDuo & iTotal® KRS". This study is designed to evaluate implant survivorship, patient satisfaction, and patient-reported outcomes of subjects who have undergone surgery with any of the following ConforMIS knee implants: the iUni®, iDuo® or iTotal® Cruciate Retaining (CR) Knee Replacement Systems.
What is the current status of trial NCT03152357?
This trial is currently completed. The enrollment target is 950 participants. The study started on 2017-04-01. Estimated completion is 2019-12-31.
What conditions does trial NCT03152357 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee, Knee Osteoarthritis.
What interventions are being tested in trial NCT03152357?
The interventions under investigation include: ConforMIS iUni, iDuo, or iTotal (CR) (DEVICE).
Who is sponsoring clinical trial NCT03152357?
This trial is sponsored by Restor3D, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03152357 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03152357's enrollment target sits among peer trials
950 10th of 112 higher than 103 of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.
RECRUITING · Phase 3
-
Mobilizing Hispanics With Knee Osteoarthritis
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
The Osteoarthritis Prevention Study
RECRUITING · NA
-
Preventing Injured Knees From osteoArthritis: Severity Outcomes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
- NCT04180930 · 950 participants
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
- NCT04895709 · 949 participants · Phase 1
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
- NCT04375033 · 952 participants · Phase 4
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI